GLP-1 Treatments
GLP-1 treatments like Semaglutide and Tirzepatide are medications that help regulate appetite, blood sugar, and metabolism. They work by increasing fullness, slowing digestion, and reducing cravings—making them effective options for sustainable weight loss when combined with healthy habits.
GLP-1 medications have been widely studied and are FDA-approved for metabolic and weight-related conditions. When prescribed appropriately and monitored by a licensed provider, they are considered safe for most patients.
All Maves GLP-1 treatments are prescribed by licensed clinicians, tailored to your goals, and supported with ongoing medical guidance. Whether you’re prescribed Semaglutide or Tirzepatide, your treatment is personalized to your needs and backed by third-party testing for quality, purity, and potency.
The science behind GLP-1 therapy
GLP-1 therapy is a customized treatment option created for Maves patients seeking clinically guided, sustainable fat loss. Ideal for those whose health profiles or treatment goals call for personalization, our compounded formulations are designed in collaboration with your Maves clinician as part of your individualized care plan.
At their core are semaglutide (single-pathway GLP-1 receptor agonist) and tirzepatide (dual GIP/GLP-1 receptor agonist) — known to reduce appetite and support blood sugar regulation. To complement your needs, your treatment may also include Vitamin B12 to support energy, or L-Carnitine to assist fat metabolism and help preserve lean muscle mass.
Each formulation is personalized to align with your goals, physiology, and journey — providing more than weight-loss support. This is not one-size-fits-all — it's your treatment, made for you.
Your journey is personal. Your medication should be too.
Both medications work by activating the same metabolic pathways your body already uses to regulate appetite and blood sugar. The right choice depends on your goals, health history, and how aggressive a fat-loss phase you're targeting.
Semaglutide is the most widely studied GLP-1 medication available. It's a strong, predictable starting point for most patients — and the more affordable entry into GLP-1 therapy.
- Single-pathway action (GLP-1)
- You could lose ~30 lbs from a 200 lb starting weight
Tirzepatide is a next-generation, dual-pathway medication. By activating both GLP-1 and GIP receptors, it tends to drive faster, more aggressive fat loss — making it a fit for patients with more weight to lose or higher performance goals.
- Dual-pathway action (GLP-1 + GIP)
- You could lose ~40 lbs from a 200 lb starting weight
Your Maves clinician will review your medical profile and recommend the option best suited to your goals.
You don't need to be on a GLP-1 forever. We typically use GLP-1 therapy in phases to cut fat:
- Induction (appetite control & titration): establish tolerance and dosing.
- Active fat-loss phase: continue while you're making steady progress.
- Consolidation & taper: gradually step down and transition to maintenance.
After a successful cut, your clinician may pause your GLP-1 and shift you to a maintenance plan or recommend a performance/recovery block (e.g., Sermorelin and training focus).
Over time, many patients do periodic cycles — short, clinician-guided "on" phases for fat loss, and "off" phases emphasizing recovery, lean-mass support, and sustainable habits. Your plan is individualized and adjusted based on progress, side effects, and goals.
Our protocols are designed to preserve lean mass while you lose fat. GLP-1 medications reduce calorie intake — and without a plan, some men can lose muscle along with fat. We recommend countering that with:
- Resistance training: 2–4 days/week
- Protein-forward nutrition
- Gradual titration to avoid overly aggressive deficits
- Recovery support (sleep and stress)
- Our Sermorelin Performance Protocol
Many patients maintain their muscle during a cut when these steps are followed.
Most side effects are mild and transient as your body adapts. They often resolve spontaneously.
Side effects may include:
- Nausea (most common)
- Vomiting or diarrhea
- Constipation
- Abdominal pain/indigestion
- Decreased appetite
How Maves manages this:
- We start low and titrate your dose for comfort and results
- You can message your clinician anytime for quick adjustments (no appointment needed)
- If needed, our doctors can prescribe ondansetron (Zofran) for nausea
Most symptoms fade over time. If side effects persist, worsen, or concern you, reach out to a healthcare professional for guidance.
Optimize performance in 3 simple steps
Complete your online assessment & provider review
Get your treatment delivered straight to your door
24/7 clinical support and personalized care
Engineer your fat loss
You could lose
30
Lose on average:
You could lose
30
Lose on average:
Your Path to Peak Performance
Complete three simple steps to receive physician-guided treatments, delivered to your door.
We’ll gather your medical information and goals, connecting you with a Maves physician for personalized recommendations.
You’ll select a personalized treatment plan with your doctor, and we'll deliver it to your doorstep.
Begin your transformation, and contact your doctor anytime for adjustments or support.
Lab tested treatments. Results you can measure.
Game-changing weight loss medication
Real patients. Real results.
Learn more about GLP-1 Treatments
Semaglutide is a single-pathway GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two metabolic pathways at once. Tirzepatide is generally more effective for fat loss but is also more expensive. Your Maves clinician will review your medical profile and recommend the option that aligns with your goals and health history.
In most cases, yes. If you're not seeing the results you want on one medication, your provider may recommend switching to the other based on your response, tolerance, and goals. Transitions are clinician-guided and adjusted to ensure safety.
GLP-1 medications are generally well tolerated when prescribed and monitored by a licensed medical provider. Some patients may experience mild side effects such as nausea, vomiting, diarrhea, constipation, abdominal discomfort, or decreased appetite. These effects are typically short-lived and resolve on their own. Serious side effects are uncommon. As with any prescription therapy, your provider will review your health history and monitor your response to treatment.
GLP-1 medications can interact with certain other prescriptions, including some diabetes medications, oral contraceptives, and drugs that require precise absorption timing. Your Maves clinician will review your full medication list and health history before prescribing to ensure GLP-1 therapy is a safe fit for you.
GLP-1 therapy may not be appropriate for everyone. Individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal conditions, or known hypersensitivity to GLP-1 agonists may not be candidates. Your licensed provider will carefully review your medical history to determine whether GLP-1 therapy is appropriate for you.
Yes. Maves plans include the medical consultation, prescription medications when approved by a licensed provider, and delivery through a licensed pharmacy. There are no hidden or additional fees for prescribed treatment. Compounded medications are prepared based on individual patient needs and are not reviewed or approved by the FDA for safety or effectiveness. A prescription is required, and results may vary.
Maves clinicians prescribe evidence-based therapies based on your goals, symptoms, and health profile. Depending on fit, that may include compounded semaglutide, compounded tirzepatide, sermorelin, NAD+, enclomiphene, and other treatments offered through Maves.
No. The entire Maves experience takes place online, from intake to medical consultation to delivery. This allows you to access licensed medical care conveniently from your home while still receiving personalized, provider-led treatment.
Maves works with a nationwide network of licensed physicians and nurse practitioners. Providers are experienced in personalized, preventative, and performance-focused care and review each patient's medical history to determine appropriate treatment options.
We don't bill insurance directly. Most patients use cash pay, HSA, or FSA funds for treatment.
Yes. Your licensed provider will monitor your progress and may adjust your treatment or dosage when clinically appropriate. Adjustments are based on your response to treatment, health history, and overall goals to ensure your plan continues to support your health safely.
You can cancel your Maves plan at any time through your online patient portal. There are no long-term contracts or cancellation fees. Please note that canceling your plan will not stop any orders that have already been processed or sent to the pharmacy. If an order is still pending, our support team can assist you.
Compounded medications are prepared by licensed pharmacies to meet individual patient needs when a personalized approach is appropriate. All compounded medications offered through Maves are prescribed by licensed medical providers and prepared by pharmacies that are licensed by state boards of pharmacy or operate as FDA-registered outsourcing facilities. These pharmacies follow strict quality, safety, and sterility standards.
Start with a quick online assessment. A licensed provider will review your information, determine whether GLP-1 therapy is a fit, and if appropriate, prescribe your treatment for delivery straight to your door.
Results vary, but many patients lose 15–20% of their body weight over a 6-month protocol when paired with proper training and nutrition. Tirzepatide tends to produce faster, larger reductions than semaglutide for most patients. Your clinician will help tailor your plan to your goals and adjust it over time based on your response.
Look feel and perform your best - every day.
